ASE Statement on Protection of Patients and Echocardiographic Service Providers During the 2020 Novel Coronvirus Outbreak


This important new guidance addresses the relatively high risk of COVID-19 among healthcare workers, particularly through the kind of close contact involved in performing echocardiograms.


ICUS appreciates the ASE’s careful attention to these urgent issues. As the global pandemic continues to unfold, please send any additional recommendations to us at: info@icus-society.org


To read the statement in full, please click here


We wish you safety and good health as we continue to confront the challenges ahead.


Global Contrast-Enhanced Ultrasound (CEUS)

Click on any country shaded in orange to see the commercially available agent(s).
 

(Agent(s) commercially available)

 

 

(No agent commercially available at this time)

 

* See package inserts for approved indications. Note that this “Global CEUS” map lists certain ultrasound contrast agents under different product names (i.e., Lumason/SonoVue and Definity/Luminity). ICUS will update this map as additional agents are approved throughout the world.

 

ICUS does not endorse or recommend the use of any ultrasound contrast agent or other medical product. In addition, ICUS does not warrant the accuracy of information provided in package inserts or herein. Medical decisions are the sole responsibility of health care providers and their patients, who are encouraged to carefully evaluate all potential risks and benefits associated with the use of any medical product or procedure including ultrasound contrast agents and (CEUS).


 

Contrast-Enhanced Ultrasound of Focal Liver Masses: A Success Story

Contrast-Enhanced Ultrasound of Focal Liver Masses: A Success Story

May 1, 2020 — ScienceDirect – Ultrasound in Medicine and Biology
Abstract
The epidemic of increasing fatty liver disease and liver cancer worldwide, and especially in Western society, has given new importance to non-invasive liver imaging. Contrast-enhanced ultrasound (CEUS) using microbubble contrast agents provides unique advantages over computed tomography (CT) and magnetic resonance imaging (MRI), the currently established methods. CEUS provides determination of malignancy and allows excellent differential diagnosis of a focal liver mass, based on arterial phase enhancement patterns and assessment (read more…)

CEUS of Focal Liver Masses: A Success Story!

CEUS of Focal Liver Masses: A Success Story!

The epidemic of increasing fatty liver disease and liver cancer worldwide, and especially in Western society, has given new importance to non-invasive liver imaging. Contrast-enhanced ultrasound (CEUS) using microbubble contrast agents provides unique advantages over computed tomography (CT) and magnetic resonance imaging (MRI), the currently established methods. Today, increased use of CEUS has provided safe and rapid diagnosis of incidentally detected liver masses, improved multidisciplinary management of nodules in a cirrhotic liver, facilitated ablative therapy for liver tumors and allowed (read more…)

Ultrasound Mediated Destruction of LMW-HA-Loaded and Folate-Conjugated Nanobubble for TAM Targeting and Reeducation

Ultrasound Mediated Destruction of LMW-HA-Loaded and Folate-Conjugated Nanobubble for TAM Targeting and Reeducation

March 23, 2020 — Dove Medical Press
Abstract
Purpose:  To synthesize and evaluate a novel folate-conjugated ultrasonic nanobubble (HA-FOL-NB) loading low-molecular-weight hyaluronic acid (LMW-HA) for specific tumor-associated macrophages (TAMs) targeting and reeducation.
Methods:  The characteristics, cytotoxicity, contrast-enhanced ultrasound imaging (CEUS), and targeting ability to TAMs of HA-FOL-NBs were investigated. The TAMs reprogramming function of HA-FOL-NBs combining ultrasound targeted nanobubble destruction was assessed as well.
Results:  HA-FOL-NBs (about 342 nm) showed remarkable contrast enhancement images, and higher targeting ability due to the folate to folate (read more…)

Ultrasound assessment of tumour oxygenation could guide cancer therapy

Ultrasound assessment of tumour oxygenation could guide cancer therapy

March 23, 2020 — Physicsworld
By Louisa Cockbill, Science writer
Pengfei Song, an assistant professor at the Beckman Institute at the University of Illinois, used ultrasound localization microscopy to visualize oxygen levels in tumours.
The centres of tumours often experience oxygen deprivation as the blood supply struggles to keep up with demand from uncontrollably proliferating tumour cells. Patients with tumours in this hypoxic state are known to have poorer outcomes, but until now, there’s been no viable non-invasive way to accurately measure tumour (read more…)

ASE Statement on Protection of Patients and Echocardiographic Service Providers During the 2019 Novel Coronavirus Outbreak

ASE Statement on Protection of Patients and Echocardiographic Service Providers During the 2019 Novel Coronavirus Outbreak

This important new guidance addresses the relatively high risk COVID-19 among healthcare workers, particularly through the kind of close contact involved in performing echocardiograms
ICUS appreciates the ASE’s careful attention to these urgent issues.  As the global pandemic continues to unfold, please send any additional recommendations to us at: info@icus-society.org. We wish you safety and good health as we continue to confront the challenges ahead.
To read the statement in full, please visit: http://icus-society.org/wp-content/uploads/2020/03/ASE-COVID-Statement-2020.pdf

Reality and possibilities in cardiology imaging

Reality and possibilities in cardiology imaging

March 17, 2020 — Dotmed/Healthcare Business News
By Tom Watson
Excerpt
Cardiac imaging is an active and growing area for clinical and technological innovations. While you can subdivide these technologies into large, highly complex market segments, the major cardiovascular solutions we will look at here are ultrasound (echocardiography), interventional fluoroscopic imaging (angiography), CT and MR.
I believe the transition of healthcare delivery from fee per procedure to a value-based model has likely suppressed activity and interest in many medical capital decisions. The ongoing merger (read more…)

Role of intraoperative ultrasound in robotic-assisted radical nephrectomy with inferior vena cava thrombectomy in renal cell carcinoma

Role of intraoperative ultrasound in robotic-assisted radical nephrectomy with inferior vena cava thrombectomy in renal cell carcinoma

March 5, 2020 — World Journal of Urology
Abstract
Purpose
To determine the impact of intraoperative ultrasound on robotic-assisted radical nephrectomy with inferior vena cava (IVC) tumor thrombectomy in renal cell carcinoma (RCC).
Methods
We retrospectively analyzed intraoperative records of 27 patients with RCC and invasion of the IVC who underwent robotic-assisted nephrectomy with tumor thrombectomy at our center between December 2017 and July 2018. Diagnostic utility and impact of intraoperative transesophageal echocardiography (TEE), intraoperative robotic-assisted ultrasonography, and intraoperative contrast-enhanced ultrasound (CEUS) on surgical management (read more…)

Implementing a Liver Contrast Program in the Sonography Laboratory – A White Paper

Implementing a Liver Contrast Program in the Sonography Laboratory – A White Paper

Mar 4, 2020 — Journal of Diagnostic Medical Sonography
The Society of Diagnostic Medical Sonography (SDMS) is pleased to announce the publication of a white paper on implementing a liver contrast program in the sonography laboratory in the January/February 2020 issue of the
In 2016 the Food and Drug Administration (FDA) approved contrast-enhanced ultrasound (CEUS) to image and characterize liver lesions as benign or malignant using gray-scale sonography. The technique includes the intravenous (IV) administration of a gas microbubble that the vascular (read more…)

Contrast enhanced ultrasound: comparing a novel modality to MRI to assess for bowel disease in pediatric Crohn’s patients

Contrast enhanced ultrasound: comparing a novel modality to MRI to assess for bowel disease in pediatric Crohn’s patients

April 5, 2020 — Translational Gastroenterology and Hepatology
Abstract
Background:
To demonstrate the feasibility and reliability of a novel imaging modality, contrast enhanced ultrasound (CEUS), in evaluating for distal small bowel inflammation in pediatric Crohn’s disease (CD), and compare this to concurrently obtained magnetic resonance imaging (MRI) findings.
Methods:
Pediatric patients diagnosed with or having suspicion of CD with small bowel involvement, whose disease merited imaging with an MRI, concurrently underwent imaging with CEUS. We assessed the ability of CEUS to demonstrate distal small bowel (read more…)

Contrast-Enhanced Ultrasound of Congenital and Infantile Hemangiomas: Preliminary Results From a Case Series

Contrast-Enhanced Ultrasound of Congenital and Infantile Hemangiomas: Preliminary Results From a Case Series

February 26, 2020 — American Journal of Roentgenology
Abstract:
OBJECTIVE. The contrast-enhanced ultrasound (CEUS) imaging features of hepatic vascular tumors in infants, including infantile hemangioma (IH) and congenital hemangioma (CH), are not well reported. Frequent inaccurate use of lesion terminology in the literature has created diagnostic confusion. The purpose of this study is to describe the CEUS features of IH and CH.
MATERIALS AND METHODS. Ten patients, ranging in age from 8 days to 16 months, with hepatic vascular tumors were included for (read more…)